Singapore Biomedical R&D Consortium
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2011
- Initiating Organization: International Enterprise, Singapore
- Initiator Type: Government
- No disease focus
- Location: Asia
Abstract
Mission
The Singapore Biomedical R&D Consortium provides standalone services based on client needs. Contract research organizations and research institutes in the island state have the technical expertise and competencies to address the needs of global biomedical companies.
The consortium aggregates key capabilities of the companies along the biomedical research and development value chain to provide a one-stop solution for global players. This equips them with the competitive edge to gain a foothold overseas.
Consortium History
June 2011: Consortium announced.
Links/Social Media Feed
Other website |
Sponsors & Partners
Dx Assays Pte Ltd. |
Experimental Therapeutics Centre (ETC.) |
Innoheart Pte Ltd. |
Maccine Ptd Ltd. |
MerLion Pharmaceuticals Pte Ltd. |
PWG Genetics Pte Ltd. |
Singapore Clinical Research Institute |